HighTower Advisors
TXG icon

HighTower Advisors’s 10x Genomics TXG Stock Holding History

HighTower Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$642K Buy
+16,752
New +$439K ﹤0.01% 2552
2025
Q4 		– Sell
-32,920
Closed -$385K – 3971
2025
Q3 		$385K Sell
32,920
-1,976
-6% -$25.8K ﹤0.01% 2827
2025
Q2 		$404K Buy
34,896
+23,716
+212% +$216K ﹤0.01% 2702
2025
Q1 		$97.6K Sell
11,180
-7,252
-39% -$91.4K ﹤0.01% 3363
2024
Q4 		$265K Sell
18,432
-668
-3% -$10.5K ﹤0.01% 2982
2024
Q3 		$430K Buy
+19,100
New +$395K ﹤0.01% 2515
2022
Q1 		– Sell
-5,707
Closed -$847K – 3694
2021
Q4 		$847K Buy
5,707
+2,442
+75% +$374K ﹤0.01% 1847
2021
Q3 		$469K Sell
3,265
-610
-16% -$105K ﹤0.01% 2092
2021
Q2 		$757K Sell
3,875
-5,692
-59% -$1.03M ﹤0.01% 1803
2021
Q1 		$1.73M Sell
9,567
-761
-7% -$131K 0.01% 1214
2020
Q4 		$1.46M Buy
+10,328
New +$1.5M 0.01% 1053
2020
Q3 		– Sell
-2,686
Closed -$239K – 2700
2020
Q2 		$239K Buy
+2,686
New +$209K ﹤0.01% 1881

Other funds holding TXG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

HighTower Advisors's TXG Position: Q2 2026 in Review

HighTower Advisors opened a new position in 10x Genomics (TXG) in Q2 2026: 16,752 shares worth $642K. The stake represents ﹤0.01% of the portfolio and ranks #2552 among its holdings. This is a return to the name: HighTower Advisors previously reported a position in TXG as recently as Q3 2025.

HighTower Advisors first reported a position in TXG in Q2 2020 and has held it in 12 quarters since. The position peaked at $1.73M in Q1 2021. 157 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • HighTower Advisors held 16,752 shares of 10x Genomics worth $642K as of Q2 2026.
  • 10x Genomics was a new HighTower Advisors position in Q2 2026.
  • 10x Genomics made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #2552 holding.
  • HighTower Advisors first reported a position in 10x Genomics in Q2 2020 and has held it in 12 quarters since.
  • HighTower Advisors's 10x Genomics position peaked at $1.73M in Q1 2021.
  • 157 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.